-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$21.86548.66% Upside
Zentalis Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Zentalis Pharmaceuticals, Inc.?
Zentalis Pharmaceuticals, Inc. has been rated by research analysts at Jefferies, Morgan Stanley, Stifel Nicolaus, Wedbush, Guggenheim, Leerink Partners in the past 90 days.